Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel stable glycosylation donor technology enabling mild conditions and orthogonal protection for high-purity pharmaceutical intermediates manufacturing.
Patent CN110669027B details novel tetrahydrofuran intermediates for prostate cancer drugs, offering streamlined synthesis and reduced manufacturing costs.
Patent CN104313072A details biocatalytic synthesis yielding high ee. Offers supply chain reliability and cost efficiency for global pharmaceutical manufacturing partners.
Patent CN110669027B discloses efficient synthesis of tetrahydrofuran carboxylic acid intermediates for prostate cancer drugs, offering scalable routes and reduced purification costs.
Patent CN110698480B details high-purity ertapenem intermediate synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110684018A reveals a novel Pd-catalyzed route for 3-indolyl rhamnosides, offering high yields and step economy for reliable pharmaceutical intermediate supply chains.
Advanced Raney Nickel reduction process for high-purity iopromide intermediates. Cost-effective, atmospheric pressure synthesis suitable for commercial scale-up.
Patent CN107298694A reveals a novel Obeticholic Acid synthesis route using cholic acid. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Novel palladium-catalyzed synthesis offers high efficiency and significant cost reduction in pharmaceutical intermediate manufacturing for global supply chains seeking reliable partners.
Patent CN103992212B details a novel cis-benvitimod synthesis enabling high-purity standards and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN103695486A reveals a novel one-pot enzymatic route for Atorvastatin intermediates, offering significant cost reduction and safer manufacturing for global API producers.
Novel synthesis method for Rucaparib intermediate offers high purity and safety. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106977488B reveals visible light promoted synthesis. Offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chains.
Advanced synthesis of Quinapril Hydrochloride via tert-butyl ester route. Eliminates hydrogenolysis, reduces impurities, and ensures high-purity API intermediate supply.
Novel biocatalytic route for sitagliptin intermediates offers high ee value and green manufacturing advantages for pharmaceutical supply chains globally.
Patent CN109608345B reveals a novel nickel-catalyzed route for Bromfenac intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102442994A details a novel atmospheric racemization method for S-Lipoic Acid, enabling cost-effective production of high-purity R-Lipoic Acid intermediates.
Patent CN117187840A details green electrochemical amidation. Offers cost reduction and supply reliability for pharma intermediates.
Advanced synthesis process for diazaspirolactam compounds offering high purity and scalable production for CNS drug development and supply chain optimization.